Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 121.58 -0.01 (-0.01%) Market Cap: 7.35 Bil Enterprise Value: 10.93 Bil PE Ratio: 17.12 PB Ratio: 1.76 GF Score: 85/100

Jazz Pharmaceuticals PLC at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 07:00PM GMT
Release Date Price: $161.9 (+0.31%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Great. Good afternoon, everyone. My name is Jess Fye. I'm one of the senior biotech analysts at JPMorgan. And we're continuing the healthcare conference today with Jazz Pharmaceuticals. I'm joined by the company's CEO, Bruce Cozadd. But before I turn it over to Bruce, I want to let you know that instead of moving across the hall to the Georgian room this year, you're going to be able to submit questions using the blue Ask-a-Question button that will send to a portal. It will let me read them to management. So that's one way you can kind of hear their responses to your questions, should you have any.

But with that, let me turn it over to Bruce.

Bruce C. Cozadd
Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO

All right, Jess, thank you for the introduction and the invitation. This is my 29th consecutive year attending JPMorgan, and I'll miss seeing many of you in-person in the hallways. Now some of you tuning in today may notice my beard is gone for the first time ever

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot